City of Hope partners with tech companies to revolutionize cancer care using AI, aiming to streamline clinical processes and enhance outcomes, showcased at ViVE 2025 in Nashville.
AI-Powered Transformation in Cancer Care
At the ViVE 2025 conference in Nashville on February 19, City of Hope executives unveiled groundbreaking initiatives in AI-driven cancer research and treatment [1]. Simon Nazarian, who joined as executive vice president in September 2024, and Nasim Eftekhari, executive director of applied AI and data science, detailed how artificial intelligence is revolutionizing their approach to patient care [1]. The institution’s primary focus lies in accelerating the transition from laboratory discoveries to practical clinical applications, what Nazarian describes as ‘the acceleration of bench to bed’ [1].
Advanced Diagnostic Capabilities
A key innovation showcased at the conference is City of Hope’s work in diagnostic imaging, where AI algorithms are being developed to predict gene mutations from digital pathology images [1]. This breakthrough technology aims to eliminate unnecessary biopsies and expedite diagnosis processes [1]. Eftekhari highlighted the potential of this research for early cancer detection and prevention, noting that these AI applications could significantly improve clinical efficiency while maintaining high standards of care [1].
Enhancing Healthcare Accessibility
The integration of AI extends beyond clinical applications to address healthcare equity challenges. City of Hope is leveraging technology to expand access to quality cancer care for underserved communities [1]. The institution’s commitment to healthcare equity was further emphasized during the conference, with Nazarian stating, ‘We are able to take our standard of care and be able to get it closer to folks who may not have access’ [1]. This initiative aligns with City of Hope’s broader mission, as one of the largest cancer research and treatment organizations in the United States [6].
Future Directions and Collaborative Efforts
Looking ahead, City of Hope’s AI strategy includes developing personalized care pathways and implementing facial recognition for streamlined check-ins [1]. The organization maintains a cautious approach to AI implementation, with Eftekhari acknowledging potential algorithmic biases that could affect different populations [1]. This strategic initiative comes as City of Hope continues to expand its presence across major U.S. cities, including Los Angeles, Orange County, Atlanta, Chicago, and Phoenix [6], demonstrating its commitment to advancing cancer care through technological innovation [8].